期刊
NATURE REVIEWS CANCER
卷 8, 期 9, 页码 714-724出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2401
关键词
-
类别
资金
- NIH [CA10617, CA104213, CA099996, CA116777]
The retinoblastoma tumour suppressor (RB) is a crucial regulator of cell-cycle progression that is invoked in response to a myriad of anti-mitogenic signals. It has been hypothesized that perturbations of the RB pathway confer a synonymous proliferative advantage to tumour cells; however, recent findings demonstrate context-specific outcomes associated with such lesions. Particularly, loss of RB function is associated with differential response to wide-ranging therapeutic agents. Thus, the status of this tumour suppressor may be particularly informative in directing treatment regimens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据